With over 22 years of experience in hospitals, health systems, associations, life sciences, physician practices, and suppliers, Erika is an experienced marketing strategist and supports the Quantitative Science Services offering with Go-to market planning and execution.
Erika Brooks
Marketing Director, Quantitative Science Services
Related resources
The five drug development questions that bring sponsors to pharmacometrics
Blog
MBMA data curation: How AI and expert meta-analysts get it right, fast
Blog
Important drug development questions that model-based meta-analysis answers
Blog
Beyond compliance: What ICH M15 means for the future of drug development
Blog
Beyond approval: Using model-informed strategies to maximize the value of ADCs
Blog
ADC dose optimization: Applying model-informed strategies in development
Blog
Why the most important Phase 3 decisions should be made before Phase 3
Blog
ICH M15 guideline: What the finalized guideline means for model-informed drug development
Blog
ADC first-in-human (FIH) dose selection: Designing FIH studies for success
Blog